Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: Study in Bartter's/Gitelman's syndromes and relevance for hypertension

Journal of Human Hypertension

Volumn 21, Issue 11, 2007, Pages 904-906

  Calo L A ^a   Davis, P A ^b   Palatini, P ^a   Semplicini, A ^a   Pessina, A C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; AMYLOID A PROTEIN; ANGIOTENSIN II; C REACTIVE PROTEIN; CHLORIDE ION; CREATININE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MANGANESE; NITRIC OXIDE; POTASSIUM ION; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SODIUM ION; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BARTTER SYNDROME; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; COLORIMETRY; CONTROLLED STUDY; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE URINE LEVEL; ENDOTHELIAL DYSFUNCTION; FEMALE; GITELMAN SYNDROME; HUMAN; HYPERTENSION; LABORATORY TEST; MALE; MICROALBUMINURIA; NEPHELOMETRY; URINALYSIS; URINARY EXCRETION;

ADULT; ALBUMINURIA; BARTTER SYNDROME; CARDIOVASCULAR DISEASES; CREATININE; ENDOTHELIAL CELLS; FEMALE; GITELMAN SYNDROME; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 35648973182     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002231     Document Type: Article

References (12)

1. Malik AR, Sultan S, Turner ST, Kullo IJ. Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults. J Hum Hypertens 2007; 21: 231-238.
2. Cottone S, Mulè G, Nardi E, Lorito MC, Guarneri M, Arsena R et al. Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 2007; 21: 167-172.
3. Caló LA, Pessina AC, Semplicini A. Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 2005; 12: 17-26.
4. Caló LA. Vascular tone control in humans: The utility of studies in Bartter's/Gitelman's syndromes. Kidney Int 2006; 69: 963-966.
5. Caló LA, Pessina. AC. RhoA/Rho-kinase pathway: Much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007; 25: 259-264.
6. Verdecchia P, Reboldi GP. Hypertension and microalbuminuria: The new detrimental duo. Blood Press 2004; 13: 198-211.
7. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17: 986-993.
8. Das UN. Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 2005; 11: 155-162.
9. Touyz RM. Role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003; 5 155-164.
10. Calc L, Davis PA, Milani M, Cantaro S, Antonello A, Favaro S et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 1999; 51: 12-17.
11. Davis PA, Mussap M, Pagnin E, Bertipaglia L, Savica V, Semplicini A et al. Early markers of inflammation in a high angiotensin II state. Results of studies in Bartter's/Gitelman's syndromes. Nephrol Dial Transpl 2006; 21: 1697-1701.
12. Davis PA, Pagnin E, Semplicini A, Avogaro A, Caló LA. Insulin signaling, glucose metabolism and the angiotensin II signaling system. Studies in Bartter's/Gitelman's syndromes. Diabetes Care 2006; 29: 469-471.